BioNews
NICE (National Institute for Health and Care Excellence)
A public body that develops and provides guidance to UK healthcare professionals and others, to ensure that the care they provide is of the best possible quality and offers the best value for money.
What happens when the watchdog blinks?
The meticulous scrutiny of the efficacy and cost-effectiveness of medical treatments and procedure by NICE is put into question by Professor Dusko Ilic when comparing the use of cryopreserved ovarian tissue and testicular tissue for restoration of fertility...
Lesbian couple told by GP to have sex with a man to have a baby
A lesbian couple from Manchester reported they were asked by a GP 'Why don't you just go out and find a man to sleep with?', to have a baby...
Cost disparity for private IVF across England
The cost of accessing private fertility treatment in England can vary by up to 30 percent, depending on where you live...
Family building is a basic human right
The American Society for Reproductive Medicine's decision to expand its definition of infertility to be inclusive of a larger group of individuals and couples seeking to build families, irrespective of sexual orientation or relationship status, aims to maximise both inclusion and access to care…
NICE recommends olaparib for the treatment of ovarian and prostate cancer
The National Institute for Health and Care Excellence has recommended the NHS funds olaparib for the maintenance treatment of advanced ovarian cancer in women with BRCA1 and 2 variants and advanced or metastatic prostate cancer in men...
Thalassaemia patients to qualify for NHS stem cell transplants
Adults with thalassemia, a severe genetic blood disorder, will be offered potentially curative stem cell transplants on the NHS for the first time...
Surveys expose impact of cost-of-living crisis on fertility patients
The rising cost of living and lack of affordable treatments are pricing fertility patients out of becoming parents, a national charity has said...
No cure, no fee? Outcome-based agreements for gene therapies
The significant price-tags associated with gene therapies are leading to questions being raised about value for both patients and payers...